Target intelligence / Profile preview

Hepatitis C virus non-structural protein 4B (NS4B) (NS4B)

Target
NS4B
Molecular classification
Viral non-structural protein, Membrane-associated protein, Enzyme
01

Overview

Hepatitis C virus non-structural protein 4B (NS4B) is a 27-kDa hydrophobic integral membrane protein essential for the viral life cycle (UniProt P26664). Its primary function is to induce the formation of the "membranous web," a specialized cytoplasmic structure derived from the endoplasmic reticulum that serves as a scaffold for the viral replication complex (Egger et al., 2002, J. Virol.). NS4B also exhibits NTPase activity and RNA-binding capabilities, which are critical for the assembly and function of the replication machinery (Einav et al., 2004, J. Virol.). In the context of disease, NS4B is indispensable for the replication of the Hepatitis C virus, which causes chronic liver inflammation, cirrhosis, and hepatocellular carcinoma (Gouttenoire et al., 2010, J. Gen. Virol.). While most current direct-acting antivirals target NS3/4A, NS5A, or NS5B, NS4B remains a significant target for drug development due to its unique role in organelle remodeling. Experimental inhibitors like clemizole and ACH-806 have demonstrated the potential to disrupt viral replication by targeting NS4B, although challenges such as drug resistance and toxicity have hindered clinical progression (Einav et al., 2008, Nature Medicine; Hafenrichter et al., 2014).

Other names
NS4Bp27HCV NS4BNon-structural protein 4B
02

Mechanism of action

Inhibition of the formation of the membranous web and disruption of the viral RNA replication complex by interfering with NS4B-RNA binding or its NTPase activity (Einav et al., 2008, Nature Medicine; Paul et al., 2011, J. Virol.).

03

Biological functions

Viral replicationMembranous web formationRNA replication complex assemblyNTPase activityRNA binding
04

Disease associations

Hepatitis C infectionLiver cirrhosisHepatocellular carcinoma
05

Safety considerations

Rapid emergence of drug resistance (Gouttenoire et al., 2010)Potential nephrotoxicity (Hafenrichter et al., 2014)Limited clinical validation compared to other HCV targets
06

Interacting drugs

Clemizole

3 more in the full profile.

07

Biomarkers

HCV RNA viral loadNS4B resistance-associated substitutions (RASs)

Beyond the preview

Go deeper on Hepatitis C virus non-structural protein 4B (NS4B) (NS4B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatitis C virus non-structural protein 4B (NS4B) (NS4B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call